Skip to main content

Kiora Pharmaceuticals Inc

KPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001372514

No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.

Other share classesKPHMW

Superinvestors holding KPRX, Q2 2026

See all superinvestors

No superinvestor reported holding KPRX in Q2 2026.